Aurobindo Pharma Limited — Losartan Exporter Profile
Indian Pharmaceutical Exporter · #14 for Losartan · $18.1M export value · DGFT Verified
Aurobindo Pharma Limited is the #14 Indian exporter of Losartan with $18.1M in export value and 159 verified shipments. Aurobindo Pharma Limited holds a 4.3% market share in Losartan exports across 5 countries. The company exports 81 pharmaceutical products worth $1.1B across 18 therapeutic categories.
Aurobindo Pharma Limited — Losartan Export Profile: Buyers & Destinations
Where Does Aurobindo Pharma Limited Export Losartan?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $6.8M | 200 | 66.3% |
| UNITED KINGDOM | $1.0M | 59 | 9.8% |
| MALTA | $750.3K | 194 | 7.3% |
| CANADA | $546.5K | 16 | 5.4% |
| UNITED STATES OF AMERICA | $384.4K | 13 | 3.8% |
| FRANCE | $270.3K | 61 | 2.6% |
| SOUTH AFRICA | $226.0K | 6 | 2.2% |
| SINGAPORE | $148.0K | 5 | 1.4% |
| TANZANIA | $52.6K | 10 | 0.5% |
| VIETNAM | $29.9K | 1 | 0.3% |
Aurobindo Pharma Limited exports Losartan to 13 countries. The largest destination is UNITED STATES accounting for 66.3% of Aurobindo Pharma Limited's Losartan shipments, followed by UNITED KINGDOM (9.8%) and MALTA (7.3%). These destinations reflect Aurobindo Pharma Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Losartan from Aurobindo Pharma Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AUROLOGISTICS LLC | UNITED STATES | $2.3M | 60 |
| AUROLOGISTICS LLC AUROBINDO PHARM | UNITED STATES | $1.2M | 34 |
| AUROLOGISTICS LLC, (AUROBINDO PHARM | UNITED STATES | $1.2M | 32 |
| AUROLOGISTICS LLC (AUROBINDO PHARMA | UNITED STATES | $1.1M | 34 |
| MILPHARM LIMITED | UNITED KINGDOM | $724.8K | 41 |
| AUROLOGISTICS LLC(AUROBINDO PHARMA | UNITED STATES | $663.9K | 27 |
| APL SWIFT SERVICES (MALTA) LTD., | MALTA | $375.9K | 93 |
| AUROLOGISTICS LLC AUROBINDO PHARMA | UNITED STATES | $277.3K | 7 |
| AURO PHARMA INC., | CANADA | $234.8K | 5 |
| ARROW GENERIQUES, | FRANCE | $220.4K | 51 |
Aurobindo Pharma Limited supplies Losartan to 43 buyers globally. The largest buyer is AUROLOGISTICS LLC (UNITED STATES), followed by AUROLOGISTICS LLC AUROBINDO PHARM (UNITED STATES) and AUROLOGISTICS LLC, (AUROBINDO PHARM (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Losartan Export Value and How Much Does Aurobindo Pharma Limited Contribute?
India exported $143.4M worth of Losartan through 10,898 shipments from 506 suppliers to 141 countries, serving 1,415 buyers globally. Aurobindo Pharma Limited contributes $18.1M to this total, accounting for 4.3% of India's Losartan exports. Aurobindo Pharma Limited ships Losartan to 13 countries through 43 buyers.
What Is the Average Shipment Value for Aurobindo Pharma Limited's Losartan Exports?
Aurobindo Pharma Limited's average Losartan shipment value is $113.7K per consignment, based on 159 shipments totaling $18.1M. The largest destination is UNITED STATES (66.3% of Aurobindo Pharma Limited's Losartan exports).
How Does Aurobindo Pharma Limited Compare to Other Indian Losartan Exporters?
Aurobindo Pharma Limited ranks #14 among 506 Indian Losartan exporters with a 4.3% market share. The top 3 exporters are ZYDUS LIFESCIENCES LIMITED ($28.1M), MICRO LABS LIMITED ($20.5M), AUROBINDO PHARMA LTD ($13.0M). Aurobindo Pharma Limited processed 159 shipments to 5 destination countries.
What Losartan Formulations Does Aurobindo Pharma Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIZID | $1.8M | 40 |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZI | $1.1M | 24 |
| LOSARTAN POTASSIUM TABLETS 100MG (LOSARTAN POTASSIUM 100MG FILM-COATED TABLETS)2X14'S | $422.9K | 16 |
| LOSARTAN POTASSIUM TABLETS 50MG (LOSARTA | $272.6K | 13 |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIZIDE TABLETS 100MG/25MG 90'S (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE TABLETS USNOS | $145.8K | 3 |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIZIDE TABLETS 50MG/12.5MG 90'S(LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE TABLETS | $109.8K | 9 |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIZIDE TABLETS 50MG/12.5MG 90'SLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE TABLETS US | $100.0K | 2 |
| LOSARTAN POTASSIUM TABLETS 100MG SARANTO 100 3X10 S | $100.0K | 2 |
| LOSARTAN POTASSIUM TABLETS 25MG (100'S)(15168PAK)(AURO-LOSARTAN 25) | $93.2K | 2 |
| LOSARTAN POTASSIUM TABLETS 100MG (LOSART | $89.8K | 3 |
Aurobindo Pharma Limited exports 358 distinct Losartan formulations including tablets, capsules, syrups, and combination drugs. The top formulation is LOSARTAN POTASSIUM AND HYDROCHLOROTHIZID with 40 shipments worth $1.8M. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Losartan to Key Markets
What Aurobindo Pharma Limited must comply with to export Losartan to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Aurobindo Pharma Limited Compare to Nearest Losartan Exporters?
Exporters ranked immediately above and below #14 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | CAPLIN POINT LABORATORIES LIMITED | $7.3M | 146 | 8 | $50.0K |
| 8 | EMIL PHARMACEUTICAL INDUSTRIES PVT LTD | $5.7M | 113 | 2 | $50.0K |
| 14 | AUROBINDO PHARMA LIMITED ★ | $5.1M | 159 | 5 | $32.2K |
| 15 | UNICHEM LABORATORIES LIMITED | $5.1M | 203 | 6 | $25.0K |
| 13 | CADILA HEALTHCARE LIMITED | $3.6M | 72 | 11 | $50.0K |
Aurobindo Pharma Limited ranks #14 among 506 Indian Losartan exporters. Average shipment value of $32.2K compared to the market average of $283.3K. The closest competitors by value are CAPLIN POINT LABORATORIES LIMITED and EMIL PHARMACEUTICAL INDUSTRIES PVT LTD.
Which Indian Ports Ship Losartan Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 1,020 | 9.4% |
| NHAVA SHEVA SEA (INNSA1) | 946 | 8.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 886 | 8.1% |
| DELHI AIR CARGO ACC (INDEL4) | 702 | 6.4% |
| DELHI AIR | 672 | 6.2% |
| JNPT/ NHAVA SHEVA SEA | 549 | 5.0% |
| MUNDRA SEA | 491 | 4.5% |
| HYDERABAD ICD | 384 | 3.5% |
What Other Cardiovascular Products Does Aurobindo Pharma Limited Export?
Aurobindo Pharma Limited also exports these cardiovascular products. Each links to the detailed product page.
About Aurobindo Pharma Limited
Aurobindo Pharma Limited exports 81 products worth $1.1B. Beyond Losartan, top products include Amoxicillin, Potassium, Pantoprazole, Clopidogrel, Rosuvastatin. View the complete Aurobindo Pharma Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Losartan — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Losartan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Aurobindo Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 582 individual customs records matching Aurobindo Pharma Limited exporting Losartan, covering 358 formulations to 13 countries via 43 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 141+ countries, 1,415+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Losartan Export Data from Aurobindo Pharma Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Aurobindo Pharma Limited's Losartan exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Aurobindo Pharma Limited
Full Company Profile →
81 products · $1.1B total trade · 18 categories
Losartan Stats
Company Overview
Top Products by Aurobindo Pharma Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Aurobindo Pharma Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Losartan. For current shipment-level data, contact TransData Nexus.